Viewing Study NCT01266005


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2025-12-26 @ 2:04 AM
Study NCT ID: NCT01266005
Status: TERMINATED
Last Update Posted: 2014-12-18
First Post: 2010-12-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients
Sponsor: Bukwang Pharmaceutical
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-08
Start Date Type: None
Primary Completion Date: 2013-08
Primary Completion Date Type: ACTUAL
Completion Date: 2014-01
Completion Date Type: ACTUAL
First Submit Date: 2010-12-19
First Submit QC Date: None
Study First Post Date: 2010-12-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-12-16
Last Update Post Date: 2014-12-18
Last Update Post Date Type: ESTIMATED